Trade Mark Journal No.2025/023 6 June 2025

WO0000001842174 (42)

Office of origin: United States of America

Date of International Registration:30 January 2025
Date of designation in the UK: 30 January 2025
Image for mark 1842174 NEUROMAP

International priority date claimed: 19 August 2024 (United States of America) (98704946)
Class 42
Drug discovery services in the field of neuroscience.

Recursion Pharmaceuticals, Inc.

Representative: David Johnson Workman Nydegger, 60 East South Temple, Suite 1000, Salt Lake City UT 84111, UNITED STATES OF AMERICA